文献速递腹部USCT

对比增强超声评估肝细胞癌肿瘤血管性预测射频消融后局部复发

Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation.
PubMed 文献 · Eur J Radiol · 2016-12-21

回顾性分析208例患者282个肝细胞癌病灶,比较CEUS与CECT检出富血供的能力,并按动脉期CEUS表现分为富血供组与非富血供组。CEUS检出富血供率78%(221/282)显著高于CECT的66%(186/282)(P<0.001);富血供组局部累积复发率41.2%(56/221)显著高于非富血供组18.4%(6/61)(P=0.007)。结论认为CEUS所示富血供是RFA后局部复发的显著危险因素。

要点

  • CEUS检出HCC富血供率78%(221/282),高于CECT的66%(186/282)(P<0.001)。
  • 动脉期CEUS富血供组局部累积复发率41.2%(56/221),非富血供组18.4%(6/61)(P=0.007)。
  • 单因素分析显示CEUS富血供是局部复发的独立危险因素(P=0.010)。

核心结论

  • CEUS观察到的HCC富血供是RFA后局部复发的显著危险因素。

研究设计与样本

  • 回顾性分析208例患者(平均年龄71.7岁,范围50-87岁,男137例、女71例)共282个HCC病灶,平均最大肿瘤直径15.7mm,均接受RFA治疗;比较CEUS与CECT检出富血供的能力,并按动脉期CEUS表现分为富血供组与非富血供组,评估局部累积复发率及单因素风险因素。

关键影像表现/征象

  • 动脉期CEUS将病灶分为富血供组(病灶内全部或部分区域较周围肝实质富血供)与非富血供组(病灶内等血供或乏血供)。
  • CEUS检出富血供HCC 221/282(78%),CECT检出186/282(66%)(P<0.001)。

诊断标准与关键数值

  • CEUS检出富血供率78%(221/282)vs CECT 66%(186/282),CEUS显著更高(P<0.001)。
  • 富血供组局部累积复发率41.2%(56/221)vs 非富血供组18.4%(6/61),富血供组显著更高(P=0.007)。
  • 单因素分析:CEUS富血供为局部复发独立危险因素(P=0.010)。

临床应用与阅片要点

  • RFA术前CEUS动脉期评估HCC富血供有助于识别局部复发高风险病灶。
  • CEUS对HCC富血供的检出能力优于CECT(78% vs 66%,P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The purpose of this study was to evaluate whether the hypervascularity of hepatocellular carcinomas (HCCs) on contrast-enhanced ultrasonography (CEUS) prior to radiofrequency ablation (RFA) is a significant risk factor for local recurrence after RFA.

MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained. Overall, 208 patients (mean age, 71.7 years; range, 50-87 years; 137 men, 71 women) with 282 HCCs treated with RFA were analyzed retrospectively. The mean maximum tumor diameter was 15.7mm. We compared the abilities of CEUS and contrast-enhanced computed tomography (CECT) to detect hypervascularity in HCCs. We then classified the HCCs into two groups according to the arterial-phase CEUS findings: a "hypervascular group" with whole or partial hypervascular areas within the lesions compared with the surrounding liver parenchyma, and a "non-hypervascular group" with isovascular or hypovascular areas within the lesions. We assessed the cumulative rate of local recurrence after RFA, and we also evaluated the risk factors for local recurrence using a univariate analysis.

RESULTS: The detection rate for hypervascular HCCs was significantly higher using CEUS (78%, 221/282) than that using CECT (66%, 186/282) (P<0.001). Using the CEUS findings, the cumulative rate of local recurrence was significantly higher in the hypervascular group (41.2%, 56/221) than in the non-hypervascular group (18.4%, 6/61) (P=0.007). A univariate analysis revealed that hypervascularity on CEUS was an independent risk factor for local recurrence (P=0.010).

CONCLUSION: Hypervascularity in HCCs as observed using CEUS is a significant risk factor for local recurrence after RFA.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Ishii T, Numata K, Hao Y, et al. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation. Eur J Radiol. 2016. PMID: 28034569. doi:10.1016/j.ejrad.2016.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。